Kevin D Staton

发表

Quantification of nanoscale nuclear refractive index changes during the cell cycle.

R. Brand, C. Bakkenist, D. Hartman, 2011, Journal of biomedical optics.

Pharmacokinetic Analysis of Dynamic 18F-Fluoromisonidazole PET Data in Non–Small Cell Lung Cancer

Andreas Rimner, Heiko Schöder, Jazmin Schwartz, 2017, The Journal of Nuclear Medicine.

Assessment of Simplified Methods for Quantification of 18F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer

J. Humm, A. Scott, A. Lammertsma, 2019, The Journal of Nuclear Medicine.

Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan

Serge K. Lyashchenko, M. Gonen, Jason S. Lewis, 2019, Clinical Cancer Research.

Nuclear Nano-architecture Markers of Gastric Cardia and Upper Squamous Esophagus Detect Esophageal Cancer “Field Effect”

Chengquan Zhao, A. Sepulveda, Sumera H Rizvi, 2013, Journal of Cancer.

Assessment of Nuclear Nano-morphology Markers for Predicting Cancer Progression Risk in Patients with Pre-cancerous Breast Lesions

R. Brand, A. Soran, R. Bhargava, 2014 .

, PhD in Vivo PeT assay of Tumor glutamine Flux and Metabolism : InHuman Trial of 18 F-( 2 S , 4 R )-4-Fluoroglutamine 1

I. Mellinghoff, J. Hsieh, Jason S. Lewis, 2018 .

Reproducibility and repeatability of semi-quantitative 18 F-fluorodihydrotestosterone ( FDHT ) uptake metrics in castration-resistant prostate cancer metastases : a prospective multi-center study

J. Humm, S. Larson, A. Scott, 2019 .

In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R)-4-Fluoroglutamine.

I. Mellinghoff, J. Hsieh, Jason S. Lewis, 2018, Radiology.

Nanoscale nuclear architecture for cancer diagnosis by spatial-domain low-coherence quantitative phase microscopy

Lin Zhang, Yang Liu, Wei Qiu, 2011, BiOS.

Nanoscale nuclear architecture for cancer diagnosis beyond pathology via spatial-domain low-coherence quantitative phase microscopy.

Shikhar Uttam, Yang Liu, Pin Wang, 2010, Journal of biomedical optics.

Preclinical Evaluation of 89Zr-Df-IAB22M2C PET as an Imaging Biomarker for the Development of the GUCY2C-CD3 Bispecific PF-07062119 as a T Cell Engaging Therapy

P. Rejto, L. Chen, J. Hardwick, 2021, Molecular Imaging and Biology.

Biodistribution and Dosimetry of 18F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies

Steven M. Larson, Kevin D. Staton, Pat Zanzonico, 2018, The Journal of Nuclear Medicine.

Investigation of depth-resolved nanoscale structural changes in regulated cell proliferation and chromatin decondensation

Shikhar Uttam, Yang Liu, Rajan K. Bista, 2013, Biomedical optics express.

Pharmacokinetic Assessment of 18F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer

J. Humm, I. Mellinghoff, J. Harding, 2019, The Journal of Nuclear Medicine.

Preclinical development and First-in-human imaging of 89Zr-Daratumumab for CD38 targeted imaging of myeloma

Jason S. Lewis, W. Weber, Kevin D Staton, 2019 .

Assessment of nuclear nanomorphology marker to improve the detection of malignancy from bile duct biopsy specimens.

A. Krasinskas, R. Brand, D. Hartman, 2014, American journal of clinical pathology.

Quantitative analysis of blood-borne 18F-FMISO metabolites in cancer patients by HPLC using an integrated high-sensitivity coincidence detector

S. Nehmeh, J. Humm, N. Lee, 2015 .

Spectral encoding of spatial frequency approach for characterization of nanoscale structures.

Yang Liu, Shikhar Uttam, Sergey A Alexandrov, 2012, Applied physics letters.

First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET

S. Larson, M. Voss, Jason S. Lewis, 2020, The Journal of Nuclear Medicine.

Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study

J. Humm, S. Larson, A. Scott, 2018, The Journal of Nuclear Medicine.